Finance
AstraZeneca shares fall £18bn on US drugmaker merger talks
AstraZeneca lost nearly £18 billion in market value following reports that chief executive Pascal Soriot is planning a merger with Bristol Myers Squibb.
MarketsIndicesCommoditiesFXRates
